10-OH-HHC vs HHC: Differences, Strength, Metabolism and Legal Status in Germany

10-OH-HHC (10-hydroxy-hexahydrocannabinol) is HHC with a hydroxyl group attached at position 10 of the same ring. It turned up on the European market in 2024, part of a wave of new semi-synthetic cannabinoids that the EU Drugs Agency says "remain poorly studied".

So what does the extra hydroxyl group change? It makes the molecule more polar, which generally means a little more water-soluble than HHC. That's chemistry. It says nothing about strength, because an OH group can make a cannabinoid more active or less active depending on where it sits, and the only way to know is to measure it. Everything known about how 10-OH-HHC feels comes from user reports and one warning from German addiction counsellors. Our guide to 10-OH-HHC effects and side effects covers those reports in detail.

You'll see this claim about 10-OH-HHC more than any other. The studies don't back it up. When your body breaks HHC down, the documented products are different ones.

Only the Leipzig team looked for 10-OH-HHC with proper reference standards. They found none. They're careful about what that means: their samples had been stored for months, and amounts below their detection limit (about 0.1 ng/mL) would have been missed. They also write that other publications have reported 8- and 10-OH-HHC forms. In the papers they cite that we could read, though, only 8-OH-HHC appears.

So where does the claim come from? Probably from THC. Your liver turns THC into 11-OH-THC, an active metabolite (more on that in our 10-OH-HHC vs THC guide), so it sounds logical that HHC would have an "OH" version too. It does. But the HHC equivalent is 11-OH-HHC, with the hydroxyl group on a different carbon. And either way, the 10-OH-HHC sold in products was made in a lab, not in anyone's liver.

Nobody knows. No receptor, animal or human data on 10-OH-HHC has been published, so any 10-OH-HHC vs HHC ranking is a guess. User reports point in every direction. Some shops call it "stronger and longer-lasting", others call it milder, and German addiction counsellors described clients with a "very strong intoxicating effect". When reports sit that far apart, they usually say more about what was in the product than about the molecule. The EU Drugs Agency warns that semi-synthetic cannabinoid products can contain undeclared cannabinoids and vary widely between batches.

HHC and HHC-P are a different story. They have real measurements.

Both measures work the same way round: a lower number means a stronger effect. Ki shows how tightly a compound binds. EC50 shows how little of it you need to switch the receptor on. You can't compare numbers from different labs directly, because the methods differ. Within each study, though, the picture is clear. 9R-HHC behaves much like THC, 9S-HHC is clearly weaker, and HHC-P is more potent than HHC. 10-OH-HHC is simply missing from the research.

Many believe 10-OH HHC is stronger than regular HHC. It offers more intense effects. This is due to its interaction with our body's receptors.

• Potency Comparison: 10-OH HHC is seen as more potent than HHC because of its stronger interaction with our endocannabinoid system.
• Effects: The effects of 10-OH HHC are usually more intense, giving a bigger impact to users.
• Duration: The effects of 10-OH HHC last longer, from four to six hours. HHC's effects last two to four hours.

Understanding the potency and duration of these cannabinoids is crucial. It helps users make informed choices based on their needs.

Because "HHC" is a mix of 9R and 9S, two HHC products can feel quite different. In mouse studies published in 2025, 9R-HHC produced the full set of cannabis-like effects and fully substituted for THC. 9S-HHC was less potent and only partly substituted. The authors conclude that these differences "may lead to a range of effects in human users depending on the ratio of the epimers consumed". So if one product seems stronger than another, the 9R:9S ratio, the dose and whatever else is in the product all play a part. The molecule's name comes after all that.

HHC-P is HHC with a longer side chain. Seven carbon atoms instead of five, the same change that turns THC into THCP. It's made from THCP rather than from HHC, and it was first reported in Europe in late 2022. 10-OH-HHC changes something else entirely. It keeps HHC's side chain and adds a hydroxyl group to the ring.

So the two shouldn't be lumped together. HHC-P has receptor data showing it's more potent than HHC, and 10-OH-HHC has none. They do share a law, the NpSG. But HHC-P has been banned under it since June 2024, while 10-OH-HHC was only covered from December 2025.

Then there's 10-OH-HHCP, which combines both changes: the longer side chain and the extra hydroxyl group. It's a separate compound with its own open questions, and our guide to 10-OH-HHCP covers it.

Standard cannabis screening tests look for a THC breakdown product. HHC's breakdown products trigger them. In the Leipzig study, urine screens came back positive in every participant, for up to 72 hours after a single oral dose. No study has looked at whether 10-OH-HHC does the same. A positive result after HHC can have consequences for your driving licence, and now that HHC is a narcotic under the BtMG, that's not something to test. Our 10-OH-HHC effects guide goes through what is and isn't known about detection.

This year the family was split up. HHC, HHC-P and their relatives first came under the NpSG together in June 2024. The government's explanatory memorandum names "HHC-AC, HHC-H und HHC-P" and says the aim was to stop the trade "ohne dabei Konsumenten und Konsumentinnen zu kriminalisieren", without criminalising consumers. Then, on 23 May 2026, HHC alone moved into the much stricter BtMG. HHC-P and 10-OH-HHC weren't part of that ordinance, so they stay under the NpSG. In practice, possessing HHC without a permit is now a criminal offence. Possessing HHC-P or 10-OH-HHC is prohibited but not in itself a crime, and the police can seize it.

10-OH-HHC isn't listed by name either. The NpSG's substance-group definition catches it, because the December 2025 ordinance extended that definition to hydroxylated derivatives. Its explanatory memorandum says that happened "aufgrund von Sicherstellungen", because these substances kept turning up in police seizures. Many pages, including several updated in 2026, still say HHC is regulated under the NpSG. That's out of date. This is a short overview, not legal advice, and our 10-OH-HHC legality guide covers the wider picture.

The previous version of this page asked "Which one should you choose?". It also called 10-OH-HHC a metabolite of HHC, claimed it was used for pain relief and gave dosing tips. None of that holds up. And "choosing" between two substances that are banned in Germany isn't advice anyone should be giving. So we rewrote the page. Every claim now has a source, and every gap in the research is named as a gap.

On 10-OH-HHC vs HHC, the evidence is lopsided. HHC has research behind it. 10-OH-HHC has a formula and a handful of warnings, so anyone who tells you it's stronger, milder or "natural" is telling you more than the evidence does.

Sources

• Höfert et al. (2026). Preliminary pharmacokinetic investigations of hydroxylated metabolites after controlled inhalative and oral consumption of hexahydrocannabinol (HHC) (Leipzig). Scientific Reports 16: 22712.
• Höfert et al. (2025). Controlled administration of HHC: pharmacokinetics and drug-test detection (Leipzig). Scientific Reports 15: 10086.
• Di Trana et al. (2024). Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol. Pharmaceuticals 17(2): 249.
• Lindbom K et al. (2024). Human metabolism of the semi-synthetic cannabinoids hexahydrocannabinol, hexahydrocannabiphorol and their acetates using hepatocytes and urine samples. Drug Testing and Analysis 17(3): 372–386.
• Nasrallah DJ, Garg NK (2023). Studies Pertaining to the Emerging Cannabinoid Hexahydrocannabinol (HHC). ACS Chemical Biology 18(9): 2023–2029.
• Persson M et al. (2025). In vitro activation of the CB1 receptor by HHC, HHC-O and HHC-P. Drug Testing and Analysis 17(4): 487–493.
• Marusich JA et al. (2025). Cannabimimetic and discriminative stimulus effects of hexahydrocannabinols in mice. Journal of Psychopharmacology 39(7): 736–743.
• Bundesinstitut für Risikobewertung (2025). Stellungnahme 019/2025 on HHC.
• GLG Gesellschaft für Leben und Gesundheit (2 April 2025). Press release: warning about a psychoactive drug.
• EU Drugs Agency (2025). European Drug Report 2025: New psychoactive substances.
• BGBl. 2026 I Nr. 150 (27th ordinance amending the BtMG annexes).
• BGBl. 2024 I Nr. 210 (Fifth ordinance amending the NpSG annex) and Bundesrat printed paper 202/24 (explanatory memorandum).
• BGBl. 2025 I Nr. 292 (Sixth ordinance amending the NpSG annex) and Bundesrat printed paper 534/25 (explanatory memorandum).